English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIn early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly’s move.
Tag: Sanofi
George Washington University to Participate in Sanofi COVID-19 Vaccine Trial
The George Washington University is a site for a phase 2 clinical trial for Sanofi’s adjuvanted recombinant protein-based COVID-19 vaccine candidate.
MD Anderson and Sanofi announce strategic collaboration to accelerate oncology research and development
The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.